Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Opthea Limited

CKDXFPNK
Healthcare
Biotechnology
$0.44
$0.00(0.00%)
U.S. Market opens in 9h 43m

Opthea Limited Fundamental Analysis

Opthea Limited (CKDXF) shows moderate financial fundamentals with a PE ratio of -3.48, profit margin of -6616.26%, and ROE of 83.96%. The company generates $0.0B in annual revenue with weak year-over-year growth of -79.95%.

Key Strengths

ROE83.96%
PEG Ratio-0.08

Areas of Concern

Operating Margin-6511.44%
Current Ratio0.22
We analyze CKDXF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -496245.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-496245.9/100

We analyze CKDXF's fundamental strength across five key dimensions:

Efficiency Score

Weak

CKDXF struggles to generate sufficient returns from assets.

ROA > 10%
-2.73%

Valuation Score

Excellent

CKDXF trades at attractive valuation levels.

PE < 25
-3.48
PEG Ratio < 2
-0.08

Growth Score

Moderate

CKDXF shows steady but slowing expansion.

Revenue Growth > 5%
-79.95%
EPS Growth > 10%
62.86%

Financial Health Score

Moderate

CKDXF shows balanced financial health with some risks.

Debt/Equity < 1
-1.23
Current Ratio > 1
0.22

Profitability Score

Weak

CKDXF struggles to sustain strong margins.

ROE > 15%
83.96%
Net Margin ≥ 15%
-6616.26%
Positive Free Cash Flow
No

Key Financial Metrics

Is CKDXF Expensive or Cheap?

P/E Ratio

CKDXF trades at -3.48 times earnings. This suggests potential undervaluation.

-3.48

PEG Ratio

When adjusting for growth, CKDXF's PEG of -0.08 indicates potential undervaluation.

-0.08

Price to Book

The market values Opthea Limited at -2.69 times its book value. This may indicate undervaluation.

-2.69

EV/EBITDA

Enterprise value stands at -3.47 times EBITDA. This is generally considered low.

-3.47

How Well Does CKDXF Make Money?

Net Profit Margin

For every $100 in sales, Opthea Limited keeps $-6616.26 as profit after all expenses.

-6616.26%

Operating Margin

Core operations generate -6511.44 in profit for every $100 in revenue, before interest and taxes.

-6511.44%

ROE

Management delivers $83.96 in profit for every $100 of shareholder equity.

83.96%

ROA

Opthea Limited generates $-2.73 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.73%

Following the Money - Real Cash Generation

Operating Cash Flow

Opthea Limited generates limited operating cash flow of $-137.36M, signaling weaker underlying cash strength.

$-137.36M

Free Cash Flow

Opthea Limited generates weak or negative free cash flow of $-137.36M, restricting financial flexibility.

$-137.36M

FCF Per Share

Each share generates $-0.10 in free cash annually.

$-0.10

FCF Yield

CKDXF converts -20.54% of its market value into free cash.

-20.54%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-3.48

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.08

vs 25 benchmark

P/B Ratio

Price to book value ratio

-2.69

vs 25 benchmark

P/S Ratio

Price to sales ratio

25615.39

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.23

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.22

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.84

vs 25 benchmark

ROA

Return on assets percentage

-2.73

vs 25 benchmark

ROCE

Return on capital employed

0.76

vs 25 benchmark

How CKDXF Stacks Against Its Sector Peers

MetricCKDXF ValueSector AveragePerformance
P/E Ratio-3.4829.45 Better (Cheaper)
ROE83.96%779.00% Weak
Net Margin-661625.61%-24936.00% (disorted) Weak
Debt/Equity-1.230.26 Strong (Low Leverage)
Current Ratio0.224.65 Weak Liquidity
ROA-272.79%-19344.00% (disorted) Weak

CKDXF outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Opthea Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-96.36%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-114.84%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-309.31%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ